Annual Total Long Term Liabilities
$125.52 M
-$25.23 M-16.74%
December 31, 2023
Summary
- As of February 24, 2025, MRSN annual total long term liabilities is $125.52 million, with the most recent change of -$25.23 million (-16.74%) on December 31, 2023.
- During the last 3 years, MRSN annual total long term liabilities has risen by +$110.21 million (+719.90%).
- MRSN annual total long term liabilities is now -16.74% below its all-time high of $150.75 million, reached on December 31, 2022.
Performance
MRSN Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$100.18 M
-$8.34 M-7.68%
September 30, 2024
Summary
- As of February 24, 2025, MRSN quarterly total long term liabilities is $100.18 million, with the most recent change of -$8.34 million (-7.68%) on September 30, 2024.
- Over the past year, MRSN quarterly long term liabilities has stayed the same.
- MRSN quarterly long term liabilities is now -33.55% below its all-time high of $150.75 million, reached on December 31, 2022.
Performance
MRSN Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
MRSN Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.7% | 0.0% |
| 3 y3 years | +719.9% | 0.0% |
| 5 y5 years | +10000.0% | 0.0% |
MRSN Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.7% | +240.7% | -33.5% | +171.9% |
| 5 y | 5-year | -16.7% | +2335.8% | -33.5% | +1844.1% |
| alltime | all time | -16.7% | >+9999.0% | -33.5% | >+9999.0% |
Mersana Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $100.18 M(-7.7%) |
| Jun 2024 | - | $108.52 M(-7.2%) |
| Mar 2024 | - | $116.98 M(-6.8%) |
| Dec 2023 | $125.52 M(-16.7%) | $125.52 M(-12.1%) |
| Sep 2023 | - | $142.78 M(-2.4%) |
| Jun 2023 | - | $146.28 M(-1.5%) |
| Mar 2023 | - | $148.50 M(-1.5%) |
| Dec 2022 | $150.75 M(+309.1%) | $150.75 M(+11.0%) |
| Sep 2022 | - | $135.83 M(+189.9%) |
| Jun 2022 | - | $46.85 M(-23.6%) |
| Mar 2022 | - | $61.28 M(+66.3%) |
| Dec 2021 | $36.85 M(+140.7%) | $36.85 M(+104.5%) |
| Sep 2021 | - | $18.02 M(+1.8%) |
| Jun 2021 | - | $17.70 M(+17.6%) |
| Mar 2021 | - | $15.05 M(-1.7%) |
| Dec 2020 | $15.31 M | $15.31 M(-2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $15.75 M(+8.4%) |
| Jun 2020 | - | $14.53 M(-4.9%) |
| Mar 2020 | - | $15.28 M(+196.5%) |
| Dec 2019 | $5.15 M(+1727.3%) | $5.15 M(-17.2%) |
| Sep 2019 | - | $6.23 M(-10.4%) |
| Jun 2019 | - | $6.95 M(+155.5%) |
| Mar 2019 | - | $2.72 M(+864.9%) |
| Dec 2018 | $282.00 K(-99.0%) | $282.00 K(-99.1%) |
| Sep 2018 | - | $33.08 M(+12.8%) |
| Jun 2018 | - | $29.34 M(-1.8%) |
| Mar 2018 | - | $29.87 M(+3.6%) |
| Dec 2017 | $28.84 M(-78.2%) | $28.84 M(-17.0%) |
| Sep 2017 | - | $34.76 M(-72.3%) |
| Jun 2017 | - | $125.44 M(+305.1%) |
| Mar 2017 | - | $30.97 M(-76.6%) |
| Dec 2016 | $132.32 M(+185.4%) | $132.32 M |
| Dec 2015 | $46.37 M | - |
FAQ
- What is Mersana Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Mersana Therapeutics?
- What is Mersana Therapeutics annual total long term liabilities year-on-year change?
- What is Mersana Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly long term liabilities year-on-year change?
What is Mersana Therapeutics annual total long term liabilities?
The current annual total long term liabilities of MRSN is $125.52 M
What is the all time high annual total long term liabilities for Mersana Therapeutics?
Mersana Therapeutics all-time high annual total long term liabilities is $150.75 M
What is Mersana Therapeutics annual total long term liabilities year-on-year change?
Over the past year, MRSN annual total long term liabilities has changed by -$25.23 M (-16.74%)
What is Mersana Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of MRSN is $100.18 M
What is the all time high quarterly long term liabilities for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly total long term liabilities is $150.75 M
What is Mersana Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, MRSN quarterly total long term liabilities has changed by $0.00 (0.00%)